Brandon Wei
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,644 | 118 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $362.21 | 15 | $0 (2024) |
| ABBVIE INC. | $231.91 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $219.01 | 10 | $0 (2024) |
| Eisai Inc. | $208.63 | 7 | $0 (2024) |
| CSL Behring | $188.49 | 8 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $186.65 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $172.35 | 10 | $0 (2024) |
| ARGENX US, INC. | $152.04 | 6 | $0 (2024) |
| GENZYME CORPORATION | $126.25 | 6 | $0 (2024) |
| Genentech USA, Inc. | $121.74 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,847 | 79 | UCB, Inc. ($338.70) |
| 2023 | $709.05 | 36 | AbbVie Inc. ($128.10) |
| 2022 | $87.92 | 3 | Horizon Therapeutics plc ($44.66) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $37.01 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Neurology | ||||||
| 12/11/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: RETT SYNDROME | ||||||
| 12/02/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Neurology | ||||||
| 11/14/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $35.45 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/24/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: RETT SYNDROME | ||||||
| 10/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: Neurology | ||||||
| 10/15/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $41.39 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/15/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/10/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Neurology | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Neurology | ||||||
| 09/18/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Neurology | ||||||
| 09/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/05/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $41.08 | General |
| Category: Neurology | ||||||
| 09/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $34.38 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Neurology | ||||||
| 08/15/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $41.84 | General |
| Category: Neurology | ||||||
About Brandon Wei
Brandon Wei is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2022. The National Provider Identifier (NPI) number assigned to this provider is 1902556962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brandon Wei has received a total of $2,644 in payments from pharmaceutical and medical device companies, with $1,847 received in 2024. These payments were reported across 118 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,644).
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Houston, TX
- Active Since 03/24/2022
- Last Updated 04/02/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1902556962
Products in Payments
- Rystiggo (Drug) $241.10
- KESIMPTA (Drug) $219.01
- BOTOX (Biological) $209.50
- Hizentra (Biological) $188.49
- Leqembi (Drug) $188.04
- VYVGART HYTRULO (Drug) $133.52
- NUPLAZID (Drug) $113.69
- HYQVIA (Biological) $107.79
- ANDEXXA (Biological) $94.08
- Briviact (Drug) $92.73
- ULTOMIRIS (Biological) $84.84
- DAYBUE (Drug) $72.96
- UPLIZNA (Biological) $72.28
- XARELTO (Drug) $60.66
- TYSABRI (Biological) $53.47
- NUEDEXTA (Drug) $50.65
- UPLIZNA (Drug) $44.66
- Evrysdi (Drug) $44.30
- AUBAGIO (Drug) $43.37
- RADICAVA (Drug) $42.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Houston
Sandeep Sahay, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $366,850
Diego Marines Copado, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $287,975
Dr. Eddie Patton, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $235,342
Naveen Pemmaraju, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $198,556
Laila Tabatabai, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $194,524
Syed Naqvi, M.d./M.b.a, M.D./M.B.A
Student in an Organized Health Care Education/Training Program — Payments: $144,401